Andreja Cokan Vujkovac

464 total citations · 1 hit paper
19 papers, 309 citations indexed

About

Andreja Cokan Vujkovac is a scholar working on Physiology, Epidemiology and Immunology. According to data from OpenAlex, Andreja Cokan Vujkovac has authored 19 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Andreja Cokan Vujkovac's work include Lysosomal Storage Disorders Research (7 papers), Protease and Inhibitor Mechanisms (4 papers) and Cardiovascular Health and Disease Prevention (4 papers). Andreja Cokan Vujkovac is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Protease and Inhibitor Mechanisms (4 papers) and Cardiovascular Health and Disease Prevention (4 papers). Andreja Cokan Vujkovac collaborates with scholars based in Slovenia, Czechia and Slovakia. Andreja Cokan Vujkovac's co-authors include Iacopo Olivotto, Maurizio Pieroni, Roberto Barriales‐Villa, Albert Hagège, Eloisa Arbustini, Aleš Linhart, Antonia Camporeale, Peter Nordbeck, Johanna Kuusisto and Päivi Pietilä‐Effati and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Cells.

In The Last Decade

Andreja Cokan Vujkovac

19 papers receiving 303 citations

Hit Papers

Cardiac Involvement in Fabry Disease 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreja Cokan Vujkovac Slovenia 8 155 106 106 89 40 19 309
Eddie Han Pin Tan Singapore 7 42 0.3× 101 1.0× 76 0.7× 48 0.5× 13 0.3× 11 278
Frederique Van de Velde Belgium 10 49 0.3× 97 0.9× 68 0.6× 218 2.4× 6 0.1× 18 365
Bianca Visciano Italy 10 233 1.5× 63 0.6× 28 0.3× 115 1.3× 70 1.8× 19 439
Eric P. Wartchow United States 11 49 0.3× 152 1.4× 16 0.2× 30 0.3× 106 2.6× 21 395
Ryuji Okamura Japan 9 53 0.3× 51 0.5× 29 0.3× 34 0.4× 16 0.4× 39 282
Sefa Tüzün Türkiye 10 68 0.4× 95 0.9× 14 0.1× 53 0.6× 13 0.3× 30 324
Raj Bhan United States 10 37 0.2× 83 0.8× 209 2.0× 72 0.8× 33 0.8× 13 433
Maria Haslip United States 9 51 0.3× 183 1.7× 24 0.2× 69 0.8× 7 0.2× 9 348
Edwina Cahill Ireland 9 31 0.2× 185 1.7× 54 0.5× 16 0.2× 12 0.3× 10 361
Rozeta Avetisyan United States 6 38 0.2× 127 1.2× 89 0.8× 16 0.2× 18 0.5× 7 276

Countries citing papers authored by Andreja Cokan Vujkovac

Since Specialization
Citations

This map shows the geographic impact of Andreja Cokan Vujkovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreja Cokan Vujkovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreja Cokan Vujkovac more than expected).

Fields of papers citing papers by Andreja Cokan Vujkovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreja Cokan Vujkovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreja Cokan Vujkovac. The network helps show where Andreja Cokan Vujkovac may publish in the future.

Co-authorship network of co-authors of Andreja Cokan Vujkovac

This figure shows the co-authorship network connecting the top 25 collaborators of Andreja Cokan Vujkovac. A scholar is included among the top collaborators of Andreja Cokan Vujkovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreja Cokan Vujkovac. Andreja Cokan Vujkovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vujkovac, Bojan, et al.. (2025). Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy. Cells. 14(3). 218–218. 1 indexed citations
2.
Vujkovac, Bojan, et al.. (2025). Transcriptomic Approach in Understanding Fabry Nephropathy: A Review of the Literature and Proof-of-Concept. Genes. 16(5). 601–601. 1 indexed citations
3.
Vujkovac, Bojan, et al.. (2023). Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy. Frontiers in Medicine. 10. 1143905–1143905. 10 indexed citations
4.
Pieroni, Maurizio, James Moon, Eloisa Arbustini, et al.. (2021). Cardiac Involvement in Fabry Disease. Journal of the American College of Cardiology. 77(7). 922–936. 177 indexed citations breakdown →
5.
Vujkovac, Bojan, et al.. (2021). Podocyturia in Fabry disease: a 10-year follow-up. Clinical Kidney Journal. 15(2). 269–277. 7 indexed citations
6.
Vujkovac, Andreja Cokan, et al.. (2020). Characteristics of Vascular Phenotype in Fabry Patients. Angiology. 72(5). 426–433. 6 indexed citations
7.
Vujkovac, Andreja Cokan, et al.. (2019). Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease. ˜The œNephron journals/Nephron journals. 144(1). 5–13. 14 indexed citations
8.
Vujkovac, Andreja Cokan, et al.. (2018). Phosphoprotein 1 (osteopontin) gene (rs4754) affects markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus. International Angiology. 37(1). 64–70. 7 indexed citations
9.
Vujkovac, Andreja Cokan, Martin Čaprnda, Ioana Mozoş, et al.. (2017). Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus. VASA. 46(5). 363–369. 12 indexed citations
10.
Ramus, Susan J., Zala Jenko Pražnikar, Andreja Cokan Vujkovac, et al.. (2017). Polymorphism rs2073618 of the osteoprotegerin gene as a potential marker of subclinical carotid atherosclerosis in Caucasians with type 2 diabetes mellitus. VASA. 46(5). 355–362. 5 indexed citations
11.
Vujkovac, Andreja Cokan, et al.. (2017). Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease. American Journal of Case Reports. 18. 644–648. 2 indexed citations
12.
Vujkovac, Andreja Cokan, Katarína Gazdíková, Martin Čaprnda, et al.. (2017). C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus. VASA. 46(3). 187–192. 18 indexed citations
13.
Makuc, Jana, et al.. (2016). Polymorphism rs5498 of the ICAM-1 gene affects the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus. Lipids in Health and Disease. 15(1). 79–79. 12 indexed citations
15.
Makuc, Jana, et al.. (2016). PECAM-1gene polymorphism (rs668) and subclinical markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. Balkan Journal of Medical Genetics. 19(1). 63–70. 3 indexed citations
16.
Vujasinović, Miroslav, et al.. (2015). Exocrine pancreatic insufficiency is not a cause of abdominal complaints in patients with Fabry disease. Wiener klinische Wochenschrift. 127(23-24). 931–934. 1 indexed citations
18.
Makuc, Jana, et al.. (2014). Polymorphism AvaII of the LDL receptor (rs5925) is associated with carotid-intima media thickness in patients with diabetes mellitus type 2. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026